nodes	percent_of_prediction	percent_of_DWPC	metapath
WF10—CD163—Scavenging of heme from plasma—HP—breast cancer	0.0651	0.348	CbGpPWpGaD
WF10—CD163—Scavenging of heme from plasma—HBA1—breast cancer	0.0424	0.227	CbGpPWpGaD
WF10—CD163—mammary gland—breast cancer	0.0342	0.0849	CbGeAlD
WF10—CD163—nipple—breast cancer	0.0283	0.0702	CbGeAlD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—HP—breast cancer	0.026	0.139	CbGpPWpGaD
WF10—MAEA—nipple—breast cancer	0.0252	0.0626	CbGeAlD
WF10—Venous thrombosis—Carboplatin—breast cancer	0.0242	0.059	CcSEcCtD
WF10—Fluid overload—Carboplatin—breast cancer	0.021	0.0512	CcSEcCtD
WF10—MAEA—embryo—breast cancer	0.0208	0.0516	CbGeAlD
WF10—CD163—endometrium—breast cancer	0.0171	0.0424	CbGeAlD
WF10—CD163—Scavenging of heme from plasma—ALB—breast cancer	0.017	0.0909	CbGpPWpGaD
WF10—MAEA—epithelium—breast cancer	0.017	0.0421	CbGeAlD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—HBA1—breast cancer	0.0169	0.0905	CbGpPWpGaD
WF10—Venous thrombosis—Letrozole—breast cancer	0.0162	0.0395	CcSEcCtD
WF10—MAEA—skin of body—breast cancer	0.0162	0.0401	CbGeAlD
WF10—CD163—uterus—breast cancer	0.0157	0.0391	CbGeAlD
WF10—CD163—pituitary gland—breast cancer	0.0155	0.0384	CbGeAlD
WF10—CD163—adipose tissue—breast cancer	0.0154	0.0382	CbGeAlD
WF10—MAEA—endometrium—breast cancer	0.0152	0.0378	CbGeAlD
WF10—Extravasation—Carboplatin—breast cancer	0.015	0.0365	CcSEcCtD
WF10—CD163—female reproductive system—breast cancer	0.0142	0.0351	CbGeAlD
WF10—MAEA—uterus—breast cancer	0.014	0.0348	CbGeAlD
WF10—CD163—adrenal gland—breast cancer	0.0138	0.0343	CbGeAlD
WF10—MAEA—pituitary gland—breast cancer	0.0138	0.0342	CbGeAlD
WF10—MAEA—adipose tissue—breast cancer	0.0137	0.0341	CbGeAlD
WF10—CD163—bone marrow—breast cancer	0.0134	0.0332	CbGeAlD
WF10—Fluid overload—Idarubicin—breast cancer	0.0133	0.0325	CcSEcCtD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—HSP90AA1—breast cancer	0.0129	0.069	CbGpPWpGaD
WF10—CD163—female gonad—breast cancer	0.0129	0.032	CbGeAlD
WF10—MAEA—female reproductive system—breast cancer	0.0126	0.0313	CbGeAlD
WF10—MAEA—adrenal gland—breast cancer	0.0123	0.0305	CbGeAlD
WF10—CD163—endocrine gland—breast cancer	0.012	0.0297	CbGeAlD
WF10—MAEA—bone marrow—breast cancer	0.0119	0.0296	CbGeAlD
WF10—MAEA—female gonad—breast cancer	0.0115	0.0285	CbGeAlD
WF10—Phlebitis—Carboplatin—breast cancer	0.011	0.0268	CcSEcCtD
WF10—MAEA—endocrine gland—breast cancer	0.0107	0.0265	CbGeAlD
WF10—Extravasation—Idarubicin—breast cancer	0.0095	0.0232	CcSEcCtD
WF10—CD163—lymph node—breast cancer	0.00828	0.0205	CbGeAlD
WF10—MAEA—lymph node—breast cancer	0.00738	0.0183	CbGeAlD
WF10—Phlebitis—Letrozole—breast cancer	0.00736	0.018	CcSEcCtD
WF10—Lung disorder—Vinorelbine—breast cancer	0.00722	0.0176	CcSEcCtD
WF10—Extravasation—Vinblastine—breast cancer	0.00705	0.0172	CcSEcCtD
WF10—Phlebitis—Idarubicin—breast cancer	0.00698	0.017	CcSEcCtD
WF10—CD163—Binding and Uptake of Ligands by Scavenger Receptors—ALB—breast cancer	0.00678	0.0363	CbGpPWpGaD
WF10—Hyponatraemia—Ixabepilone—breast cancer	0.00676	0.0165	CcSEcCtD
WF10—Extravasation—Melphalan—breast cancer	0.00671	0.0164	CcSEcCtD
WF10—Extravasation—Goserelin—breast cancer	0.00654	0.016	CcSEcCtD
WF10—Venous thrombosis—Paclitaxel—breast cancer	0.00637	0.0155	CcSEcCtD
WF10—Lung disorder—Irinotecan—breast cancer	0.00596	0.0145	CcSEcCtD
WF10—Extravasation—Vinorelbine—breast cancer	0.00586	0.0143	CcSEcCtD
WF10—Extravasation—Thiotepa—breast cancer	0.00559	0.0137	CcSEcCtD
WF10—Venous thrombosis—Capecitabine—breast cancer	0.00523	0.0128	CcSEcCtD
WF10—Phlebitis—Vinblastine—breast cancer	0.00518	0.0126	CcSEcCtD
WF10—Extravasation—Mitoxantrone—breast cancer	0.00483	0.0118	CcSEcCtD
WF10—Extravasation—Irinotecan—breast cancer	0.00483	0.0118	CcSEcCtD
WF10—Extravasation—Gemcitabine—breast cancer	0.00471	0.0115	CcSEcCtD
WF10—Extravasation—Fluorouracil—breast cancer	0.00463	0.0113	CcSEcCtD
WF10—Infection—Carboplatin—breast cancer	0.00462	0.0113	CcSEcCtD
WF10—Infection—Lapatinib—breast cancer	0.00436	0.0106	CcSEcCtD
WF10—Phlebitis—Vinorelbine—breast cancer	0.00431	0.0105	CcSEcCtD
WF10—Hyponatraemia—Melphalan—breast cancer	0.00426	0.0104	CcSEcCtD
WF10—Infection—Fulvestrant—breast cancer	0.00401	0.00979	CcSEcCtD
WF10—Oedema—Toremifene—breast cancer	0.00398	0.00972	CcSEcCtD
WF10—Extravasation—Paclitaxel—breast cancer	0.00394	0.00962	CcSEcCtD
WF10—Hyponatraemia—Vinorelbine—breast cancer	0.00373	0.00909	CcSEcCtD
WF10—Body temperature increased—Carboplatin—breast cancer	0.00368	0.00898	CcSEcCtD
WF10—Venous thrombosis—Epirubicin—breast cancer	0.00364	0.00889	CcSEcCtD
WF10—Phlebitis—Mitoxantrone—breast cancer	0.00355	0.00867	CcSEcCtD
WF10—Oedema—Exemestane—breast cancer	0.00351	0.00856	CcSEcCtD
WF10—Infection—Exemestane—breast cancer	0.00348	0.0085	CcSEcCtD
WF10—Venous thrombosis—Doxorubicin—breast cancer	0.00337	0.00822	CcSEcCtD
WF10—Extravasation—Docetaxel—breast cancer	0.00334	0.00815	CcSEcCtD
WF10—Oedema—Ixabepilone—breast cancer	0.00331	0.00807	CcSEcCtD
WF10—Infection—Ixabepilone—breast cancer	0.00329	0.00802	CcSEcCtD
WF10—Body temperature increased—Fulvestrant—breast cancer	0.00319	0.00779	CcSEcCtD
WF10—Oedema—Anastrozole—breast cancer	0.00312	0.0076	CcSEcCtD
WF10—Oedema—Letrozole—breast cancer	0.00312	0.0076	CcSEcCtD
WF10—Infection—Anastrozole—breast cancer	0.00309	0.00755	CcSEcCtD
WF10—Infection—Letrozole—breast cancer	0.00309	0.00755	CcSEcCtD
WF10—Hyponatraemia—Mitoxantrone—breast cancer	0.00307	0.0075	CcSEcCtD
WF10—Hyponatraemia—Irinotecan—breast cancer	0.00307	0.0075	CcSEcCtD
WF10—Lung disorder—Methotrexate—breast cancer	0.00297	0.00724	CcSEcCtD
WF10—Infection—Raloxifene—breast cancer	0.00294	0.00717	CcSEcCtD
WF10—Infection—Idarubicin—breast cancer	0.00294	0.00717	CcSEcCtD
WF10—Phlebitis—Paclitaxel—breast cancer	0.0029	0.00707	CcSEcCtD
WF10—Lung disorder—Epirubicin—breast cancer	0.00278	0.00678	CcSEcCtD
WF10—Body temperature increased—Exemestane—breast cancer	0.00277	0.00676	CcSEcCtD
WF10—Body temperature increased—Ixabepilone—breast cancer	0.00262	0.00638	CcSEcCtD
WF10—Lung disorder—Doxorubicin—breast cancer	0.00257	0.00627	CcSEcCtD
WF10—Hyponatraemia—Paclitaxel—breast cancer	0.00251	0.00611	CcSEcCtD
WF10—Body temperature increased—Letrozole—breast cancer	0.00246	0.00601	CcSEcCtD
WF10—Body temperature increased—Anastrozole—breast cancer	0.00246	0.00601	CcSEcCtD
WF10—Phlebitis—Docetaxel—breast cancer	0.00246	0.00599	CcSEcCtD
WF10—Extravasation—Methotrexate—breast cancer	0.00241	0.00587	CcSEcCtD
WF10—Infection—Chlorambucil—breast cancer	0.00238	0.00581	CcSEcCtD
WF10—Phlebitis—Capecitabine—breast cancer	0.00238	0.0058	CcSEcCtD
WF10—Body temperature increased—Raloxifene—breast cancer	0.00234	0.0057	CcSEcCtD
WF10—Body temperature increased—Idarubicin—breast cancer	0.00234	0.0057	CcSEcCtD
WF10—Extravasation—Epirubicin—breast cancer	0.00225	0.0055	CcSEcCtD
WF10—Oedema—Tamoxifen—breast cancer	0.00213	0.0052	CcSEcCtD
WF10—Hyponatraemia—Docetaxel—breast cancer	0.00212	0.00518	CcSEcCtD
WF10—Infection—Tamoxifen—breast cancer	0.00212	0.00517	CcSEcCtD
WF10—Oedema—Melphalan—breast cancer	0.00209	0.00509	CcSEcCtD
WF10—Extravasation—Doxorubicin—breast cancer	0.00208	0.00509	CcSEcCtD
WF10—Infection—Melphalan—breast cancer	0.00207	0.00506	CcSEcCtD
WF10—Hyponatraemia—Capecitabine—breast cancer	0.00206	0.00502	CcSEcCtD
WF10—Oedema—Goserelin—breast cancer	0.00204	0.00497	CcSEcCtD
WF10—Infection—Goserelin—breast cancer	0.00202	0.00494	CcSEcCtD
WF10—Body temperature increased—Chlorambucil—breast cancer	0.00189	0.00462	CcSEcCtD
WF10—Infection—Vinorelbine—breast cancer	0.00181	0.00442	CcSEcCtD
WF10—Infection—Thiotepa—breast cancer	0.00173	0.00422	CcSEcCtD
WF10—Phlebitis—Epirubicin—breast cancer	0.00166	0.00404	CcSEcCtD
WF10—Body temperature increased—Goserelin—breast cancer	0.00161	0.00393	CcSEcCtD
WF10—Phlebitis—Doxorubicin—breast cancer	0.00153	0.00374	CcSEcCtD
WF10—Oedema—Irinotecan—breast cancer	0.0015	0.00367	CcSEcCtD
WF10—Oedema—Mitoxantrone—breast cancer	0.0015	0.00367	CcSEcCtD
WF10—Infection—Mitoxantrone—breast cancer	0.00149	0.00365	CcSEcCtD
WF10—Infection—Irinotecan—breast cancer	0.00149	0.00365	CcSEcCtD
WF10—Oedema—Gemcitabine—breast cancer	0.00147	0.00357	CcSEcCtD
WF10—Infection—Gemcitabine—breast cancer	0.00146	0.00355	CcSEcCtD
WF10—Body temperature increased—Vinorelbine—breast cancer	0.00144	0.00352	CcSEcCtD
WF10—Oedema—Fluorouracil—breast cancer	0.00144	0.00352	CcSEcCtD
WF10—Hyponatraemia—Epirubicin—breast cancer	0.00143	0.0035	CcSEcCtD
WF10—Infection—Fluorouracil—breast cancer	0.00143	0.00349	CcSEcCtD
WF10—Body temperature increased—Thiotepa—breast cancer	0.00138	0.00336	CcSEcCtD
WF10—Hyponatraemia—Doxorubicin—breast cancer	0.00133	0.00323	CcSEcCtD
WF10—Oedema—Paclitaxel—breast cancer	0.00123	0.00299	CcSEcCtD
WF10—Infection—Paclitaxel—breast cancer	0.00122	0.00297	CcSEcCtD
WF10—Body temperature increased—Mitoxantrone—breast cancer	0.00119	0.0029	CcSEcCtD
WF10—Body temperature increased—Irinotecan—breast cancer	0.00119	0.0029	CcSEcCtD
WF10—Body temperature increased—Gemcitabine—breast cancer	0.00116	0.00283	CcSEcCtD
WF10—Body temperature increased—Fluorouracil—breast cancer	0.00114	0.00278	CcSEcCtD
WF10—Oedema—Docetaxel—breast cancer	0.00104	0.00254	CcSEcCtD
WF10—Infection—Docetaxel—breast cancer	0.00103	0.00252	CcSEcCtD
WF10—Oedema—Capecitabine—breast cancer	0.00101	0.00246	CcSEcCtD
WF10—Infection—Capecitabine—breast cancer	0.001	0.00244	CcSEcCtD
WF10—Body temperature increased—Paclitaxel—breast cancer	0.00097	0.00237	CcSEcCtD
WF10—Body temperature increased—Docetaxel—breast cancer	0.000822	0.00201	CcSEcCtD
WF10—Body temperature increased—Capecitabine—breast cancer	0.000796	0.00194	CcSEcCtD
WF10—Infection—Methotrexate—breast cancer	0.000744	0.00182	CcSEcCtD
WF10—Oedema—Epirubicin—breast cancer	0.000701	0.00171	CcSEcCtD
WF10—Infection—Epirubicin—breast cancer	0.000697	0.0017	CcSEcCtD
WF10—Oedema—Doxorubicin—breast cancer	0.000649	0.00158	CcSEcCtD
WF10—Infection—Doxorubicin—breast cancer	0.000645	0.00157	CcSEcCtD
WF10—Body temperature increased—Methotrexate—breast cancer	0.000592	0.00145	CcSEcCtD
WF10—Body temperature increased—Epirubicin—breast cancer	0.000554	0.00135	CcSEcCtD
WF10—Body temperature increased—Doxorubicin—breast cancer	0.000513	0.00125	CcSEcCtD
